• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. 3D KNEE; FEMUR, NONPOROUS, 3D, SIZE5, RT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. 3D KNEE; FEMUR, NONPOROUS, 3D, SIZE5, RT Back to Search Results
Catalog Number 233-02-105
Health Effect - Clinical Code No Code Available (3191)
Date of Event 01/08/2018
Type of Reportable Event Serious Injury
Event or Problem Description
Revision surgery - due to the patient's knee becoming loose.
 
Additional Manufacturer Narrative
The reason for this revision surgery was due to knee loosening.The previous surgery and the revision detailed in this investigation occurred 7.4 years apart.There is no information in this complaint about any patient injuries, activities, or accidents that may have contributed to the need for this revision surgery.There are no reported pre-existing patient health conditions.Initial or prolonged hospitalization was required.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhrs) show that the reported component used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to this event.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The device was verified to have gone through an acceptable sterilization process and was within it's expiration date at the time of use during the previous surgery.The root cause of this complaint was a revision surgery due to knee loosening.There were no findings during this investigation that indicate that the reported device was defective.There are multiple factors that may contribute to an event that are outside of the control of djo surgical.Inventory containment is not required as there are no indications of a product or process issue affecting implant safety or effectiveness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3D KNEE
Common Device Name
FEMUR, NONPOROUS, 3D, SIZE5, RT
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key7185760
Report Number1644408-2018-00033
Device Sequence Number16644521
Product Code MBH
UDI-Device Identifier00888912111225
UDI-Public(01)00888912111225
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K032905
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2010
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/31/2015
Device Catalogue Number233-02-105
Device Lot Number54050869
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 01/08/2018
Supplement Date Received by Manufacturer02/19/2018
Initial Report FDA Received Date01/12/2018
Supplement Report FDA Received Date02/20/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
324-01-104, LOT 233B1014; 392-19-605, LOT 54034898; 324-01-104, LOT 233B1014; 392-19-605, LOT 54034898
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age72 YR
-
-